Copyright Reports & Markets. All rights reserved.

Global Type 2 Diabetes Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 DPP-4 Inhibitors
      • 1.4.3 Biguanides
      • 1.4.4 Insulins
      • 1.4.5 SGLT-2 Inhibitors
      • 1.4.6 α-Glucosidase Inhibitors
      • 1.4.7 Other
    • 1.5 Market by Application
      • 1.5.1 Global Type 2 Diabetes Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Children
      • 1.5.3 Middle-Aged Person
      • 1.5.4 Aged
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Type 2 Diabetes Therapeutics Market Size
    • 2.2 Type 2 Diabetes Therapeutics Growth Trends by Regions
      • 2.2.1 Type 2 Diabetes Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Type 2 Diabetes Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Type 2 Diabetes Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Type 2 Diabetes Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Type 2 Diabetes Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Type 2 Diabetes Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Type 2 Diabetes Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Type 2 Diabetes Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Type 2 Diabetes Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Type 2 Diabetes Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Type 2 Diabetes Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Type 2 Diabetes Therapeutics Market Size (2014-2019)
    • 5.2 Type 2 Diabetes Therapeutics Key Players in United States
    • 5.3 United States Type 2 Diabetes Therapeutics Market Size by Type
    • 5.4 United States Type 2 Diabetes Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Type 2 Diabetes Therapeutics Market Size (2014-2019)
    • 6.2 Type 2 Diabetes Therapeutics Key Players in Europe
    • 6.3 Europe Type 2 Diabetes Therapeutics Market Size by Type
    • 6.4 Europe Type 2 Diabetes Therapeutics Market Size by Application

    7 China

    • 7.1 China Type 2 Diabetes Therapeutics Market Size (2014-2019)
    • 7.2 Type 2 Diabetes Therapeutics Key Players in China
    • 7.3 China Type 2 Diabetes Therapeutics Market Size by Type
    • 7.4 China Type 2 Diabetes Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Type 2 Diabetes Therapeutics Market Size (2014-2019)
    • 8.2 Type 2 Diabetes Therapeutics Key Players in Japan
    • 8.3 Japan Type 2 Diabetes Therapeutics Market Size by Type
    • 8.4 Japan Type 2 Diabetes Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Type 2 Diabetes Therapeutics Market Size (2014-2019)
    • 9.2 Type 2 Diabetes Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Type 2 Diabetes Therapeutics Market Size by Type
    • 9.4 Southeast Asia Type 2 Diabetes Therapeutics Market Size by Application

    10 India

    • 10.1 India Type 2 Diabetes Therapeutics Market Size (2014-2019)
    • 10.2 Type 2 Diabetes Therapeutics Key Players in India
    • 10.3 India Type 2 Diabetes Therapeutics Market Size by Type
    • 10.4 India Type 2 Diabetes Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Type 2 Diabetes Therapeutics Market Size (2014-2019)
    • 11.2 Type 2 Diabetes Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Type 2 Diabetes Therapeutics Market Size by Type
    • 11.4 Central & South America Type 2 Diabetes Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 AstraZeneca
      • 12.1.1 AstraZeneca Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Type 2 Diabetes Therapeutics Introduction
      • 12.1.4 AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.1.5 AstraZeneca Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Type 2 Diabetes Therapeutics Introduction
      • 12.2.4 Novartis Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Novo Nordisk
      • 12.3.1 Novo Nordisk Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Type 2 Diabetes Therapeutics Introduction
      • 12.3.4 Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.3.5 Novo Nordisk Recent Development
    • 12.4 Boehringer Ingelheim
      • 12.4.1 Boehringer Ingelheim Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Type 2 Diabetes Therapeutics Introduction
      • 12.4.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.4.5 Boehringer Ingelheim Recent Development
    • 12.5 Bristol-Myers Squibb
      • 12.5.1 Bristol-Myers Squibb Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Type 2 Diabetes Therapeutics Introduction
      • 12.5.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.5.5 Bristol-Myers Squibb Recent Development
    • 12.6 Eli Lilly
      • 12.6.1 Eli Lilly Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Type 2 Diabetes Therapeutics Introduction
      • 12.6.4 Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.6.5 Eli Lilly Recent Development
    • 12.7 Merck
      • 12.7.1 Merck Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Type 2 Diabetes Therapeutics Introduction
      • 12.7.4 Merck Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.7.5 Merck Recent Development
    • 12.8 Sanofi
      • 12.8.1 Sanofi Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Type 2 Diabetes Therapeutics Introduction
      • 12.8.4 Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2014-2019)
      • 12.8.5 Sanofi Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Type 2 Diabetes Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Type 2 Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Type 2 Diabetes Therapeutics development in United States, Europe and China.

      The key players covered in this study
      AstraZeneca
      Novartis
      Novo Nordisk
      Boehringer Ingelheim
      Bristol-Myers Squibb
      Eli Lilly
      Merck
      Sanofi

      Market segment by Type, the product can be split into
      DPP-4 Inhibitors
      Biguanides
      Insulins
      SGLT-2 Inhibitors
      α-Glucosidase Inhibitors
      Other

      Market segment by Application, split into
      Children
      Middle-Aged Person
      Aged

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Type 2 Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Type 2 Diabetes Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Type 2 Diabetes Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now